NVSEF - Blackstone said to explore sale of Anthos developer of blood thinners
2023-12-04 15:35:38 ET
More on Blackstone
- Blackstone: Short-Term Upside May Be Capped (Rating Downgrade)
- Blackstone Vs. Apollo: The Winner Might Shock You
- Bumble to repurchase stock, interests from Blackstone for $100M
- Blackstone raises $2.6B for eighth real estate secondaries fund
For further details see:
Blackstone said to explore sale of Anthos, developer of blood thinners